APPLICATION
ANDA205050
TYPE
ANDA
ORIGINAL APPROVAL
2017-07-07
LATEST ACTION
2024-08-07
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
TRAVOPROSTPrescription
TRAVOPROST 0.004% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2024-08-07Manufacturing (CMC) · Supplement 12 · unknownAP
2024-03-29Labeling · Supplement 4 · standardAP
2024-03-29Labeling · Supplement 3 · standardAP
2017-07-07UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.